BeStock  
Stocks › Biotechnology › ADMA

ADMA Biologics ADMA

US equityMarket cap rank #2453Biotechnology
$13.17 −$0.17 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.30 +0.99%
Open$13.26
Prev close$13.34
Day range$13.10 – $13.47
Volume2.45M
Market cap$2.92B
P/E (TTM)17.1
Dividend yield–

ADMA Stock News

Headlines matching ADMA Biologics or the ADMA ticker, most recent first.

  • CCORF Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $18Market news · 6 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Hold Rating, Cuts Target Price to $12 NegativeMarket news · 6 Aug 2026 · Direct mention
  • ADMA Biologics Q2 Adj. EPS $0.16 Misses $0.17 Estimate, Sales $124.395M Miss $131.658M Estimate NegativeBenzinga · 6 Aug 2026 · Direct mention
  • 4: ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.SEC · 29 Jul 2026 · Direct mention
  • Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $17 NegativeMarket news · 15 Jul 2026 · Direct mention
  • Raymond James Initiates ADMA Biologics(ADMA.US) With Buy Rating, Announces Target Price $21Market news · 10 Jun 2026 · Direct mention
  • Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $20 NegativeMarket news · 7 May 2026 · Direct mention
  • CCORF Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $21Market news · 5 May 2026 · Direct mention
  • ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.SEC · 4 Apr 2026 · Direct mention
  • Raymond James Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $21 NegativeMarket news · 21 Apr 2026 · Direct mention
  • Mizuho Securities Maintains ADMA Biologics(ADMA.US) With Buy Rating, Cuts Target Price to $24 NegativeMarket news · 14 Apr 2026 · Direct mention
  • Cantor Fitzgerald Downgrades ADMA Biologics(ADMA.US) to Hold Rating, Maintains Target Price $30 NegativeMarket news · 26 Mar 2026 · Direct mention
  • ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Director Guiheen Lawrence P.SEC · 18 Mar 2026 · Direct mention
  • ADMA Biologics | 4: Statement of changes in beneficial ownership of securities-Officer Kestenberg-Messina Kaitlin M.SEC · 11 Mar 2026 · Direct mention
  • Cantor Fitzgerald Maintains ADMA Biologics(ADMA.US) With Buy Rating, Maintains Target Price $30Market news · 26 Feb 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ADMA.

Sign in to join the discussion.

Scroll to Top